Results of the first human clinical trial of the HIV drug, Gammora, have shown that it can eliminate up to 99 per cent of the virus within four weeks of treatment.
The results released Sunday show that Gammora significantly reduced the viral load in human subjects by killing infected cells without harming healthy ones, unlike antiretroviral drugs which suppress the spreading of the virus.
APOPTOSIS
The study was done by researchers from Zion Medical, an Israeli biotech company, and the Hebrew University of Jerusalem.
“The drug triggers the self-destruction of the infected cell called apoptosis. It has the potential to cure HIV-infected patients by destroying all cells carrying the HIV genome.